Showing results (31-40 of 220) with videos related to
Sort By:
Pageof 22
Cancer|December 1, 1991
Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I studyT Saphner, D C Tormey, M AlbertiniJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancerT Saphner, D C Tormey, R GrayJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Annual hazard rates of recurrence for breast cancer after primary therapyT Saphner, D C Tormey, R GrayMedical and Pediatric Oncology|January 1, 1992
Continuous-infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: feasibility studyT Saphner, D C Tormey, P CareyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancerS G Taylor, M W Knuiman, L A Sleeper, et al.Journal of the National Cancer Institute|December 18, 1996
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology GroupD C Tormey, R Gray, H C FalksonCanadian Medical Association Journal|March 17, 1973
Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinomaF H Stutz, D C Tormey, J BlomJournal of Surgical Oncology|January 1, 1980
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosineD C Tormey, T P Waalkes, C W GehrkeCancer|June 1, 1977
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophinD C Tormey, T P Waalkes, R M SimonPageof 22